Logo image of MIR

MIRION TECHNOLOGIES INC (MIR) Stock Fundamental Analysis

NYSE:MIR - New York Stock Exchange, Inc. - US60471A1016 - Common Stock - Currency: USD

21.47  -0.07 (-0.32%)

Premarket: 21.67 +0.2 (+0.93%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MIR. MIR was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. MIR has an average financial health and profitability rating. While showing a medium growth rate, MIR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MIR was profitable.
In the past year MIR had a positive cash flow from operations.
In the past 5 years MIR always reported negative net income.
In the past 5 years MIR always reported a positive cash flow from operatings.
MIR Yearly Net Income VS EBIT VS OCF VS FCFMIR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

With a Return On Assets value of 0.37%, MIR perfoms like the industry average, outperforming 49.19% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.68%, MIR is in line with its industry, outperforming 50.81% of the companies in the same industry.
MIR has a Return On Invested Capital of 1.45%. This is comparable to the rest of the industry: MIR outperforms 53.23% of its industry peers.
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROIC 1.45%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MIR Yearly ROA, ROE, ROICMIR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

MIR has a Profit Margin (1.13%) which is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 5.09%, MIR is in the better half of the industry, outperforming 66.13% of the companies in the same industry.
In the last couple of years the Operating Margin of MIR has declined.
The Gross Margin of MIR (46.70%) is better than 80.65% of its industry peers.
In the last couple of years the Gross Margin of MIR has grown nicely.
Industry RankSector Rank
OM 5.09%
PM (TTM) 1.13%
GM 46.7%
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
MIR Yearly Profit, Operating, Gross MarginsMIR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

MIR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MIR has more shares outstanding than it did 1 year ago.
MIR has a worse debt/assets ratio than last year.
MIR Yearly Shares OutstandingMIR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M 200M
MIR Yearly Total Debt VS Total AssetsMIR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.63 indicates that MIR is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.63, MIR is doing worse than 62.10% of the companies in the same industry.
MIR has a debt to FCF ratio of 9.95. This is a negative value and a sign of low solvency as MIR would need 9.95 years to pay back of all of its debts.
MIR's Debt to FCF ratio of 9.95 is in line compared to the rest of the industry. MIR outperforms 54.84% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that MIR is somewhat dependend on debt financing.
The Debt to Equity ratio of MIR (0.57) is worse than 74.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Altman-Z 2.63
ROIC/WACC0.15
WACC9.53%
MIR Yearly LT Debt VS Equity VS FCFMIR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

MIR has a Current Ratio of 2.54. This indicates that MIR is financially healthy and has no problem in meeting its short term obligations.
MIR has a Current ratio (2.54) which is in line with its industry peers.
A Quick Ratio of 2.01 indicates that MIR has no problem at all paying its short term obligations.
MIR has a better Quick ratio (2.01) than 60.48% of its industry peers.
Industry RankSector Rank
Current Ratio 2.54
Quick Ratio 2.01
MIR Yearly Current Assets VS Current LiabilitesMIR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

MIR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 27.78%, which is quite impressive.
Looking at the last year, MIR shows a small growth in Revenue. The Revenue has grown by 7.88% in the last year.
The Revenue has been growing by 14.36% on average over the past years. This is quite good.
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%

3.2 Future

Based on estimates for the next years, MIR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.50% on average per year.
Based on estimates for the next years, MIR will show a small growth in Revenue. The Revenue will grow by 7.15% on average per year.
EPS Next Y17.8%
EPS Next 2Y18.39%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue Next Year6.86%
Revenue Next 2Y7.2%
Revenue Next 3Y7.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MIR Yearly Revenue VS EstimatesMIR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MIR Yearly EPS VS EstimatesMIR Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 46.67 indicates a quite expensive valuation of MIR.
MIR's Price/Earnings ratio is in line with the industry average.
MIR is valuated expensively when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
MIR is valuated quite expensively with a Price/Forward Earnings ratio of 37.36.
MIR's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 35.28. MIR is around the same levels.
Industry RankSector Rank
PE 46.67
Fwd PE 37.36
MIR Price Earnings VS Forward Price EarningsMIR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MIR.
MIR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 59.49
EV/EBITDA 29.87
MIR Per share dataMIR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MIR does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as MIR's earnings are expected to grow with 19.50% in the coming years.
PEG (NY)2.62
PEG (5Y)N/A
EPS Next 2Y18.39%
EPS Next 3Y19.5%

0

5. Dividend

5.1 Amount

MIR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MIRION TECHNOLOGIES INC

NYSE:MIR (8/7/2025, 8:04:01 PM)

Premarket: 21.67 +0.2 (+0.93%)

21.47

-0.07 (-0.32%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-31 2025-07-31/amc
Earnings (Next)10-27 2025-10-27
Inst Owners82.68%
Inst Owner Change-1.08%
Ins Owners4.41%
Ins Owner Change0.53%
Market Cap4.98B
Analysts84.44
Price Target21.83 (1.68%)
Short Float %6.22%
Short Ratio3.84
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)8.05%
Max EPS beat(2)26.94%
EPS beat(4)3
Avg EPS beat(4)9.22%
Min EPS beat(4)-11.99%
Max EPS beat(4)26.94%
EPS beat(8)6
Avg EPS beat(8)9.28%
EPS beat(12)8
Avg EPS beat(12)6.21%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.86%
Min Revenue beat(2)-0.35%
Max Revenue beat(2)2.07%
Revenue beat(4)3
Avg Revenue beat(4)1.25%
Min Revenue beat(4)-0.35%
Max Revenue beat(4)2.76%
Revenue beat(8)5
Avg Revenue beat(8)1.52%
Revenue beat(12)8
Avg Revenue beat(12)1.82%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.1%
PT rev (3m)11.96%
EPS NQ rev (1m)-3.82%
EPS NQ rev (3m)-11.73%
EPS NY rev (1m)0%
EPS NY rev (3m)3.37%
Revenue NQ rev (1m)-0.09%
Revenue NQ rev (3m)-1.33%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.63%
Valuation
Industry RankSector Rank
PE 46.67
Fwd PE 37.36
P/S 5.62
P/FCF 59.49
P/OCF 39.55
P/B 3.41
P/tB N/A
EV/EBITDA 29.87
EPS(TTM)0.46
EY2.14%
EPS(NY)0.57
Fwd EY2.68%
FCF(TTM)0.36
FCFY1.68%
OCF(TTM)0.54
OCFY2.53%
SpS3.82
BVpS6.3
TBVpS-1.66
PEG (NY)2.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.68%
ROCE 1.83%
ROIC 1.45%
ROICexc 1.62%
ROICexgc 10.04%
OM 5.09%
PM (TTM) 1.13%
GM 46.7%
FCFM 9.45%
ROA(3y)-5.01%
ROA(5y)-6.97%
ROE(3y)-9.58%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y18.71%
ROICexcg growth 5YN/A
ROICexc growth 3Y10.74%
ROICexc growth 5YN/A
OM growth 3Y18.9%
OM growth 5Y-14%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.09%
GM growth 5Y1.66%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 9.95
Debt/EBITDA 4.48
Cap/Depr 29.99%
Cap/Sales 4.76%
Interest Coverage 250
Cash Conversion 67.76%
Profit Quality 837%
Current Ratio 2.54
Quick Ratio 2.01
Altman-Z 2.63
F-Score8
WACC9.53%
ROIC/WACC0.15
Cap/Depr(3y)24.94%
Cap/Depr(5y)26.34%
Cap/Sales(3y)5.02%
Cap/Sales(5y)4.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y17.8%
EPS Next 2Y18.39%
EPS Next 3Y19.5%
EPS Next 5YN/A
Revenue 1Y (TTM)7.88%
Revenue growth 3Y12.07%
Revenue growth 5Y14.36%
Sales Q2Q%7.63%
Revenue Next Year6.86%
Revenue Next 2Y7.2%
Revenue Next 3Y7.15%
Revenue Next 5YN/A
EBIT growth 1Y1704%
EBIT growth 3Y33.25%
EBIT growth 5Y-1.65%
EBIT Next Year389.13%
EBIT Next 3Y85.73%
EBIT Next 5YN/A
FCF growth 1Y542.86%
FCF growth 3Y18.28%
FCF growth 5YN/A
OCF growth 1Y696.84%
OCF growth 3Y22.74%
OCF growth 5Y46.47%